10 Participants Needed

Deep Brain Stimulation for Cerebral Palsy

MS
SW
Overseen BySarah Wang, PhD, CCRP
Age: < 65
Sex: Any
Trial Phase: Academic
Sponsor: University of California, San Francisco
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Approved in 1 JurisdictionThis treatment is already approved in other countries

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial explores a new treatment method called Deep Brain Stimulation (DBS) to manage movement issues in children and young adults with cerebral palsy. DBS involves placing a device in the brain to send electrical signals to the cerebellum, aiming to improve movement symptoms. Participants must have a specific type of cerebral palsy with a history of brain injury and have found little relief from medication. The trial will test different stimulation settings to identify the most effective one for each participant. As an unphased trial, this study offers a unique opportunity to contribute to groundbreaking research and potentially benefit from a novel treatment approach.

Do I need to stop my current medications for the trial?

The trial does not specify if you need to stop taking your current medications. However, it mentions that participants should have a history of trying oral medications without adequate relief, so it's possible you may need to continue them.

What prior data suggests that this device is safe for treating movement symptoms related to cerebral palsy?

Research has shown that cerebellar deep brain stimulation (DBS) is generally safe for individuals with cerebral palsy. In studies involving patients with dystonic and spastic cerebral palsy, participants tolerated the treatment well. These studies included children and young adults, similar to those who might join the current trial. One study found that DBS significantly improved muscle stiffness in both arms and legs, suggesting it could help with movement issues.

No major safety concerns emerged in these studies, indicating the treatment is relatively safe, though individual reactions may vary. Prospective trial participants should discuss any concerns with a healthcare professional.12345

Why are researchers excited about this trial?

Researchers are excited about cerebellar deep brain stimulation (DBS) for cerebral palsy because it offers a novel approach by directly targeting the brain's motor control regions. Unlike traditional therapies, such as physical therapy and muscle relaxants that primarily manage symptoms, DBS aims to enhance motor function by electrically stimulating the cerebellum. This innovative method could potentially improve movement and coordination more effectively and sustainably. Additionally, the ability to fine-tune stimulation settings for each individual means that treatment can be highly personalized, increasing the chances of meaningful improvements in quality of life for those with cerebral palsy.

What evidence suggests that Cerebellar Deep Brain Stimulation is effective for treating movement symptoms in cerebral palsy?

Research has shown that deep brain stimulation (DBS) can improve movement in individuals with movement disorders. In earlier studies, patients with cerebral palsy demonstrated better hand movements, coordination, walking, head control, and speech after receiving DBS. This trial will administer cerebellar DBS to all participants, targeting the cerebellum, which typically remains undamaged in cerebral palsy, making it a promising focus area. DBS has successfully treated other movement disorders by using electrical signals to control movement. This success suggests that DBS could also help manage movement symptoms in individuals with cerebral palsy.12456

Who Is on the Research Team?

MS

Marta San Luciano Palenzuela

Principal Investigator

University of California, San Francisco

Are You a Good Fit for This Trial?

This trial is for children and young adults aged 7-25 with dyskinetic cerebral palsy (DCP), who have tried oral medications without enough relief. They should be able to attend follow-up visits, have a history of brain injury before their motor symptoms started, and not have major cerebellar abnormalities on an MRI.

Inclusion Criteria

No gross cerebellar abnormalities observed and reported on structural MRI
My family and I have chosen surgery with DBS for my movement disorder.
My mobility is moderately to severely limited.
See 13 more

Exclusion Criteria

Pregnancy: all women of child-bearing potential will be required to have a negative urine pregnancy test prior to undergoing their surgical procedure
I have severe joint stiffness or bone deformities that would not show improvement.
I need treatments like diathermy, electroconvulsive therapy, or magnetic stimulation.
See 3 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Open-label Phase

Participants undergo an open label phase to titrate stimulation and determine optimal stimulation settings

20 weeks

Randomized Blinded Phase

Participants start three cycles of randomized, paired 8-week exposure periods, each pair including effective stimulation followed by sham stimulation, or vice versa

24 weeks
Weekly evaluations

Follow-up

Participants are monitored for safety and effectiveness after treatment

4 weeks

What Are the Treatments Tested in This Trial?

Interventions

  • Cerebellar Deep Brain Stimulation
Trial Overview The study tests the safety of Deep Brain Stimulation (DBS) in the cerebellum using Medtronic Percept Neurostimulators to treat movement disorders caused by cerebral palsy. It includes videotaped movement analysis, gait analysis, and monitoring physiological and neuroimaging markers.
How Is the Trial Designed?
2Treatment groups
Active Control
Placebo Group
Group I: Effective stimulationActive Control1 Intervention
Group II: Sham stimulationPlacebo Group1 Intervention

Cerebellar Deep Brain Stimulation is already approved in United States for the following indications:

🇺🇸
Approved in United States as Cerebellar Deep Brain Stimulation for:

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of California, San Francisco

Lead Sponsor

Trials
2,636
Recruited
19,080,000+

National Institute of Neurological Disorders and Stroke (NINDS)

Collaborator

Trials
1,403
Recruited
655,000+

National Institutes of Health (NIH)

Collaborator

Trials
2,896
Recruited
8,053,000+

Published Research Related to This Trial

Dyskinetic cerebral palsy (DCP) presents significant treatment challenges due to its complex motor symptoms, including chorea, athetosis, and dystonia, which are often not effectively managed with pharmacological options.
Deep brain stimulation (DBS) targeting the basal ganglia or cerebellum shows promise as a therapeutic approach for selected patients with DCP, based on a review of the largest available studies on this treatment.
Deep brain stimulation for dystonia due to cerebral palsy: A review.Elia, AE., Bagella, CF., Ferré, F., et al.[2018]
Bilateral deep brain stimulation (DBS) targeting the dentate nucleus in three patients with dyskinetic cerebral palsy (DCP) was found to be safe and resulted in subjective and objective improvements in motor function, as measured by the Burke-Fahn-Marsden Dystonia Rating Scale.
The study suggests that the cerebellum may be a promising target for DBS in DCP patients, as it is often spared from hypoxic ischemic damage, but further research with larger sample sizes and long-term follow-up is needed to confirm these preliminary findings.
Cerebellar deep brain stimulation for the treatment of movement disorders in cerebral palsy.Cajigas, I., Morrison, MA., Luciano, MS., et al.[2023]
Deep brain stimulation of the dentate nucleus (DN DBS) is a safe and well-tolerated procedure for patients with cerebellar symptoms, showing no serious adverse events in a pilot trial with five participants.
While DN DBS did not achieve statistical significance in improving overall ataxia scores, it did lead to significant improvements in tremor severity and patients' global impression of change, indicating potential benefits in specific symptoms.
Safety and Outcomes of Dentate Nucleus Deep Brain Stimulation for Cerebellar Ataxia.Cury, RG., França, C., Duarte, KP., et al.[2022]

Citations

Cerebellar Deep Brain Stimulation in Cerebral PalsyPatients experienced subjective improvement in motor function including ease of hand movements and coordination, gait, head control, speech, ...
Cerebellar Deep Brain Stimulation for Movement Disorders ...The purpose of this study is to test the safety of placing Deep Brain Stimulators (DBS) in a part of the brain called the cerebellum and using electrical ...
Cerebellar deep brain stimulation for the treatment of ...The cerebellum has been posited as an attractive target for treatment of DCP because it is frequently spared from hypoxic ischemic damage.
Cerebellar deep brain stimulation for movement disordersDeep brain stimulation (DBS) targeting at cerebellum can be an effective tool to treat these movement disorders.
Protocol for combined N-of-1 trials to assess cerebellar ...DBS in traditional targets (globus pallidus and motor thalamus) can improve motor, disability and pain ratings in DCP, but motor and quality of ...
Cerebellar deep brain stimulation for the treatment of ...In 10 patients with dystonic and spastic CP, anterior cerebellar high-frequency DBS significantly improved upper- and lower-limb spasticity and ...
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security